Related Experiment Video
Updated: May 10, 2026
08:25
Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
Published on: September 26, 2022
Heparin treatment for allergic conjunctivitis in the experimental BALB/c model
T Kocatürk1, O Kocatürk, A Kaplan
1Department of Ophthalmology, Faculty of Medicine, Adnan Menderes University, Aydın, Turkey. tolgakocaturk@yahoo.com
Ophthalmic Research
|June 19, 2013
Summary
Topical heparin and dexamethasone effectively reduce mast cell infiltration in a mouse model of allergic eye disease. Heparin shows comparable efficacy to dexamethasone in treating experimental allergic conjunctivitis.
Area of Science:
- Ophthalmology
- Immunology
- Pharmacology
Background:
- Allergic conjunctivitis involves mast cell infiltration in the ocular tissues.
- Dexamethasone is a common treatment, but alternatives are sought.
Purpose of the Study:
- To compare the efficacy of topical heparin versus dexamethasone in inhibiting mast cell infiltration in a mouse model of allergic conjunctivitis.
Main Methods:
- A mouse model of allergic conjunctivitis was established.
- Mice were treated with topical dexamethasone, heparin, or a control solution.
- Histopathological and molecular examinations were performed on ocular tissues.
Main Results:
- Both dexamethasone and heparin significantly reduced mast cell infiltration compared to the allergy group.
- Heparin demonstrated comparable inhibitory effects to dexamethasone.
Conclusions:
- Topical heparin is a potential treatment for IgE-induced allergic eye disease.
- Heparin is as effective as dexamethasone in experimental acute allergic eye disease.
